22:49:57 EDT Fri 26 Jul 2024
Enter Symbol
or Name
USA
CA



Q:PRTC - PURETECH HEALTH PLC SPON ADS EACH REP 10 ORD SHS - Website unknown - click to update
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
PRTC - Q0.321.33·23.670.122.51+0.462.11.7372322.51  22.51  22.5134.00  17.0816:00:00Jul 2315 min RT 2¢

Recent Trades - Last 10 of 23
Time ETExPriceChangeVolume
16:00:00Q23.100.701
15:59:17Q22.5350.1351
14:38:25Q23.100.703
13:31:12Q22.00-0.401
13:30:23Q22.790.391
11:06:37Q22.510.46100
11:06:37Q22.510.46275
11:06:37Q22.510.46500
11:06:37Q22.510.46230
11:06:36Q22.510.46100

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-07-23 08:26U:PRTCNews ReleasePureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial
2024-06-24 12:00U:PRTCNews ReleasePureTech Health: Completion of Tender Offer & Total Voting Rights
2024-06-24 02:00U:PRTCNews ReleasePureTech Health: Results of the Tender Offer
2024-06-20 02:00U:PRTCNews ReleasePureTech Announces Change of Board Role
2024-06-18 07:05U:PRTCNews ReleasePureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team
2024-06-13 13:15U:PRTCNews ReleasePureTech Health: Results of Annual General Meeting
2024-06-06 12:38U:PRTCNews ReleasePureTech Health: Result of General Meeting
2024-05-29 08:09U:PRTCNews ReleasePureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
2024-05-23 07:00U:PRTCNews ReleasePureTech to Present at the Jefferies Global Healthcare Conference
2024-05-21 07:05U:PRTCNews ReleasePureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
2024-05-20 02:00U:PRTCNews ReleasePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
2024-05-09 07:05U:PRTCNews ReleasePureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
2024-05-07 07:05U:PRTCNews ReleasePureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
2024-04-25 05:22U:PRTCNews ReleasePureTech Announces Annual Results for Year Ended December 31, 2023
2024-04-18 02:00U:PRTCNews ReleasePureTech Health: Notice of Results
2024-04-16 07:00U:PRTCNews ReleasePureTech Announces Completion of Enrollment in Phase 2b ELEVATE IPF Trial of LYT-100 (Deupirfenidone) in Idiopathic Pulmonary Fibrosis
2024-04-11 07:00U:PRTCNews ReleasePureTech Receives FDA Fast Track Designation for LYT-200 in Head and Neck Cancers
2024-04-09 02:00U:PRTCNews ReleasePureTech Launches Seaport Therapeutics with $100 Million Oversubscribed Series A and Announces Management Transitions
2024-03-19 03:00U:PRTCNews ReleasePureTech Proposes $100 Million Capital Return
2024-03-18 09:52U:PRTCNews ReleaseBristol Myers Squibb Completes Acquisition of PureTech's Founded Entity Karuna Therapeutics for $14 Billion